Trial Profile
A Real-life Experience With Ponatinib in Chronic Myeloid Leukemia patients: A Multicenter, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2019
Price :
$35
*
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2016 New trial record